Drinking coffee can cut the risk of womb cancer, suggests study.
According to the World Cancer Research Fund report, coffee contains antioxidants which may boost health, the BBC reported.
Coffee
Coffee is a great beverage prepared from the seeds of Coffea plant. Different types of coffee include espresso, cappuccino, Café latte, frappe, iced coffee.
Advertisement
However, experts said that there is not yet enough evidence to recommend drinking coffee to protect against the disease.
Researchers at Imperial College, London also said that women can reduce their risk of developing the disease with at least 38 minutes of daily exercise and keeping a healthy weight.
Source: ANI
Source: ANI
Quiz on Coffee
'Coffee sets the blood in motion and stimulates the muscles; it accelerates the digestive processes, chases away sleep, and gives us the capacity to engage a little longer in the exercise of our intellects.' - Honoré de Balzac (paraphrasing Brillat-Savarin) Traité des Excitants Modernes (1838). Coffee - summary. This quiz will give you the details.
Advertisement
 Coffee Grounds: Future Energy ResourceCoffee grounds might serve as a cheaper and cleaner energy source, say researchers. | Advertisement
|
Coffee Consumption Linked to Reduced Risk of Prostate and Womb Cancer
Drinking around four to six cups of coffee every day may reduce the risk of prostate cancer and womb cancer, according to a new study.
Advertisement
Recommended Readings
Latest Cancer News
The new study uncovers the efficacy of fixed-duration combination treatment in patients with high-risk leukemia.
The approvals of pipeline drugs such as momelotinib and Vonjo for myelofibrosis (a rare type of blood cancer) over some time will handle the critical unmet needs.
New study highlights the dual role that blood vessels can play in cancer immunotherapy and eliciting anti-tumor immune responses or even preventing breast cancer spread.
New study evaluated the association between exposure to the chemical agent orange and the development of blood cancer with increased bleeding and blood clot formation.
Study suggests two-year immunotherapy treatment for advanced lung cancer may be reasonable